BIO Investor Forum closing plenary:

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech…

Full text: http://www.biotech-now.org/business-and-investments/business-of-biotech/2014/10/bio-investor-forum-closing-plenary-how-fragile-is-the-biotech-rally-after-five-positive-years

Source

Biotechnow, 2014-10-13.

Supplier

AbbVie
Biotechnology Innovation Organization (BIO)
Dicerna Pharmaceuticals, Inc.
Forest Laboratories
GlyocoMimetic
MPM Capital
ROTH Capital Partners
US Food and Drug Administration (FDA)

Share